SAB Biotherapeutics Income Statement (2020-2025) | SABS

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 16.93M18.21M14.68M11.06M11.80M6.35M3.59M2.16M0.58M0.09M1.27M0.31M0.94M0.26M-0.08M0.11M-0.07M-0.06M-0.04M
Operating items
Research & Development 12.78M18.68M15.07M10.65M13.32M8.58M7.35M7.14M4.54M3.66M4.02M4.30M8.15M6.82M7.83M7.65M7.66M7.00M8.97M
Selling, General & Administrative 3.33M2.40M3.60M7.75M5.19M4.31M4.04M2.88M3.45M2.90M2.57M14.88M4.19M3.64M3.48M2.47M3.11M2.74M3.71M
Operating Expenses 16.11M21.08M18.67M18.40M18.51M12.89M11.40M10.02M7.98M6.56M6.59M19.18M12.34M10.46M11.31M10.12M10.77M9.73M12.68M
Operating Income 0.81M-2.87M-3.99M-7.34M-6.71M-6.54M-7.81M-7.86M-7.40M-6.48M-5.32M-18.87M-11.39M-10.20M-11.31M-10.01M-10.77M-9.73M-12.68M
EBIT 0.81M-2.87M-3.99M-7.34M-6.71M-6.54M-7.81M-7.86M-7.40M-6.48M-5.32M-18.87M-11.39M-10.20M-11.31M-10.01M-10.77M-9.73M-12.68M
Non-operating items
Interest & Investment Income 0.01M0.01M0.00M0.01M0.01M0.02M0.02M0.03M0.06M0.03M0.01M0.48M0.50M0.37M0.28M0.14M0.06M0.01M0.66M
Other Non Operating Income 0.67M-0.07M0.00M7.79M1.67M0.00M0.03M0.10M0.34M0.48M0.37M0.75M0.85M0.55M0.30M0.77M
Non Operating Income 0.60M-0.07M-0.07M-0.45M7.79M1.67M0.73M0.01M0.05M-0.40M0.22M-3.98M6.36M2.87M0.96M-1.39M5.58M-0.38M58.12M
Net income details
EBT 1.41M-2.94M-4.06M-11.55M1.08M-4.87M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.94M-10.78M-9.78M-12.07M
Tax Provisions 0.09M-0.09M
Profit After Tax 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.87M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-11.39M-5.20M-10.11M45.45M
Income from Continuing Operations 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.94M-10.78M-9.78M-12.07M
Consolidated Net Income 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.94M-10.78M-9.78M-12.07M
Income towards Parent Company 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.85M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-9.94M-10.78M-9.78M-12.07M
Net Income towards Common Stockholders 1.41M-2.94M-4.06M-11.55M0.99M-4.78M-7.08M-7.87M-7.35M-6.88M-5.10M-22.86M-5.03M-7.34M-10.35M-11.39M-5.20M-10.11M-12.07M
Additional items
EPS (Basic) 0.05-0.11-0.16-0.410.02-0.11-0.16-0.18-1.46-1.36-0.97-3.85-0.54-0.79-1.12-1.23-0.56-1.090.50
EPS (Weighted Average and Diluted) 0.05-0.11-0.16-0.410.02-0.11-0.16-1.81-1.46-1.36-0.97-3.85-0.54-0.79-1.12-1.23-0.56-1.09-0.21
Shares Outstanding (Weighted Average) 4.39M1.29M1.48M4.39M4.35M4.30M4.30M4.30M4.30M4.30M5.04M5.23M5.23M9.23M9.23M9.23M9.23M9.29M9.29M10.41M
Shares Outstanding (Diluted Average) 25.97M25.97M43.05M43.04M4.35M5.04M5.04M5.24M5.52M9.24M9.26M9.26M9.26M9.29M9.29M77.86M
EBITDA 0.81M-2.87M-3.99M-7.34M-6.71M-6.54M-7.81M-7.86M-7.40M-6.48M-5.32M-18.87M-11.39M-10.20M-11.31M-10.01M-10.77M-9.73M-12.68M
Interest Expenses 0.08M0.07M0.08M0.07M0.07M0.07M0.07M0.09M0.09M0.08M0.07M0.08M0.08M0.09M0.08M0.07M0.07M0.06M0.04M
Shares Outstanding 25.97M25.97M25.97M25.97M4.35M43.50M43.58M43.58M5.09M5.09M5.29M5.29M9.28M9.28M9.28M9.28M9.34M9.35M9.35M47.55M
Tax Rate 8.561.90